Dexcom's hospital glucose monitor leads latest FDA breakthrough designations ⭐️#Dexcom has led the latest batch of FDA breakthrough device designations, securing the regulatory privileges for a version of its continuous glucose monitor technology designed for use in hospital settings.
⭐️After the start of the COVID-19 pandemic, the FDA issued guidance allowing glucose monitors indicated for home use to be used in a hospital setting, letting patients track and report their own blood glucose levels to reduce health care workers' exposure to the virus. ✳️#Dexcom is seeking clearance for its #CGMs to be used in a hospital setting. 🔥The breakthrough designation covers a small, wearable sensor that continuously measures glucose levels and a linked transmitter that sends the data wirelessly to a smart device.
